The precise genetic events leading to myelodysplastic syndromes (MDSs) and leukemic transformation remain poorly defined. Even less is known about adult familial MDS. We report an adult MDS family in whom enriched tissue-specific transcripts were derived by subtractive hybridization of cDNA from the mononuclear and CD34 þ cells of affected and unaffected family members. These expression libraries were then hybridized to Genome Discovery arrays containing 18 404 genes and expressed sequence tags, and several clusters of differentially expressed genes were identified. A group of 21 genes was underexpressed (45-fold) in affected vs unaffected family members, and among these were transcription factors and genes involved in myeloid differentiation, such as ZNF140 and myeloid nuclear differentiation antigen (MNDA). Another group of 36 genes was overexpressed (45-fold), and these encoded proteins belonging to signaling pathways, such as Ras-and Fos-related genes. The top two genes downregulated in this MDS family, ZNF140 and MNDA, were similarly altered in another MDS family, and in some cases of sporadic MDS. Our data suggest that we have identified genes differentially expressed in adult familial MDS, and that alteration of some of these genes may also be important for the evolution of different stages or severity of sporadic MDS.
Introduction
Myelodysplastic syndrome (MDS) comprise a heterogeneous group of disorders characterized by ineffective hematopoiesis with an increased propensity to myeloid leukemia transformation. 1 The loss of chromosomal material is the most prevalent cytogenetic abnormality observed in over 70% of cases, and has become an important factor in the assessment of prognosis. Deletions of the entire chromosome 5 or 7, or the deletion of the long arm of these chromosomes [del(5q)/del(7q)] are frequently observed. 2 The identification of recurring deletions in MDS suggests the loss of critical genes involved in the regulation of growth and differentiation of myeloid cells. For example, deleted segments such as 5q31 involve the loss of several hematopoietic growth factors and their receptors. 3 However, no links have been established between the loss of these genes and any type of MDS. Recent reports have highlighted the importance of gene profiling for the elucidation of genes and pathways transcriptionally altered in sporadic MDS. [4] [5] [6] However, little is known about the genes involved in familial MDS, although some insight has been gained from the analysis of children with neurofibromatosis type I 7 and familial monosomy 7. 8 Even less is known about adult familial MDS. Ho et al 9 described a kindred with an autosomal-dominant platelet disorder and propensity to develop acute myeloid leukemia with a linkage to genetic markers on chromosome 21q22.1-22.2. Olopade et al 10 described a kindred in which AML or MDS developed in five members over three generations. Three out of five affected members were karyotyped and loss of genetic material from chromosome 5q was observed in their leukemic cells. Grimwade et al 11 from this institution describe two sisters, aged 38 and 36 years, both of whom had MDS and interstitial deletion of 5q. However, in another MDS family, no linkage was found to the loci on chromosomes 5q31 and 7q22, which are commonly involved in sporadic adult MDS. 12 Similarly, detailed studies of familial AML (with autosomaldominant transmission) and loss of the long arm of chromosome 5 was observed, but no genetic linkage to the portion of 5q that is commonly deleted was identified. 13 Thus, the majority of reports suggest that deletions of chromosomes 5q and 7q may be associated with progression and not initiation of disease.
We previously identified 13 kindreds, where two or more firstdegree relatives developed MDS in their adult life. 14, 15 Studies of the molecular features of familial MDS/AML, such as cDNA expression profiling between affected and unaffected members of such families, may shed further light on the molecular pathways involved in these diseases. Furthermore, expression profiles between familial and sporadic MDS cases may reveal the differences and similarities of genes and pathways dysregulated in adult familial vs adult sporadic MDS. Here, we describe differential gene expression profiles of CD34 þ and mononuclear cells (MNCs) from affected vs unaffected members of a single adult MDS family and relate some of the changes to another MDS family and to patients with sporadic forms of MDS.
Materials and methods

Preparation of cell samples
Local ethical committee approval was obtained for use of bone marrow aspirates from patient and donor samples (LREC 02-098). Bone marrow aspirates were obtained from one healthy and unaffected and two affected siblings of one MDS family; these samples were used to generate expression libraries for affected and unaffected individuals. Bone marrow samples were also obtained from two affected siblings in another MDS family, and from seven sporadic MDS patients (four refractory anemia (RA), one RARS and two RAEB). MNCs were prepared from these samples by Ficoll-Hypaque density centrifugation. CD34 þ cells were prepared by positive selection using anti-CD34 þ microbeads (Miltenyi Biotec), and subjected to MiniMACs magnetic cell separation columns (Miltenyi Biotec) according to the manufacturer's instructions. Mobilized peripheral blood CD34 þ cells were obtained from normal donors at King's College Hospital and prepared as described above. A total of 1 Â 10 5 CD34 þ cells were cytospun onto glass slides and fixed in cold methanol for 15 min and cold acetone for 1 min and air-dried. The slides were stained for CD34 antibody to assess purity. We estimated that the isolated CD34 þ cells had a purity of 495%. T cells were isolated from normal peripheral blood and stimulated to proliferate with PHA, followed by IL-2, as described previously, 16 and MNCs were positively isolated using anti-CD4/CD8-conjugated microbeads, according to the manufacturer's instruction (Dynal). The MDS cell lines, P39 17 and MDS92L 18 and the promyelocytic leukemia cell line HL60, 19 were cultured in RPMI containing 10% fetal bovine serum, with the latter requiring IL-3 supplementation.
RNA preparation and SMART cDNA synthesis of cDNA from small amounts of RNA Total RNA was isolated from BM MNC and CD34 þ cells using TRIzol reagent (Life Technologies, Gaithersburg MI, USA). RNA (3 mg) was converted into first-strand cDNA, utilizing the SMART PCR cDNA Synthesis kit (Clontech). Using a 10 mM modified oligo-(dT) 30 primer (Clontech), CDS primer, 5
0 -AAGCAGTGG-TAACAACGCAGAGTACT30N-1N-3 0 (Clontech) and 10 mm SMART II oligo 5 0 -AAGCAGTGGTAACAACGCAGAG-TACGCGGG-3 0 (Clontech) in a total volume of 5 ml. After a 2 min incubation at 721C, premixes were made and aliquoted containing 2 ml 5 Â First Strand buffer (250 mm Tris-HCl, pH 8.3, 375 mm KCl, 30 mm MgCl 2 ) (Clontech), 0.2 mM of each deoxyribonucleotide (Clontech, 20 mM DTT and 200 ml of Superscript II reverse transcriptase (LifeTechnologies, Gaithersburg, MI, USA). The 10 ml reactions were mixed and incubated at 421C for 1 h in an air incubator. The first-strand reactions were then diluted in 40 ml of 10 mM Tris-HCl pH 7.6, 1 mM EDTA buffer and heated for 7 min at 721C.
Suppression subtractive hybridization (SSH)
The digested cDNA were initially size fractionated by column chromatography according to the manufacturer's instructions (Clontech) and then SSH was performed (Clontech) according to the method described by Diatchenko et al. 22 SSH was performed with cDNA from the CD34 þ and MNC cells of affected siblings II-5 and II-6, and one unaffected sibling (II-3) control. To derive cDNA libraries enriched for transcripts in the affected individuals, cDNA from II-5 and II-6 were used as testers and unaffected cDNA (II-3) as the driver (libraries II-5 and II-6, respectively). To derive libraries that were enriched for transcripts in the unaffected family member, unaffected cDNA (II-3) was used as a tester and affected cDNA (II-5 and II-6) as the driver (libraries II-3(1)and II-3(2), respectively). The SSH was performed as follows: tester cDNA was divided into two portions and ligated each to two different adaptors, adaptor 1 5 0 -ACCTGCCCGG-3 0 and adaptor 2R 5 0 -ACCTGCCCGG-3 0 , according to the manufacturer's instructions (Clontech). In the first hybridization, an excess of denatured driver (450 ng) was added to each sample of denatured Tester (12 ng), incubated for 8 h at 681C. In the second hybridization step, the two primary hybridization samples were mixed together without denaturing and more freshly denatured driver cDNA (300 ng) was added, and incubated overnight at 681C. Differentially expressed cDNAs were amplified by two suppression PCR amplifications using the Advantage cDNA PCR kit (Clontech).
Subtraction efficiency test
This was performed to compare the abundance of known genes before and after subtraction to assess the efficiency of this technique. In a total of 30 ml PCR reactions, the following reagents were added: 1/10 volume PCR reaction buffer (Advantage Clontech), 6 32 Arabidopsis and Drosophilia control RNA and 24 orientation markers. The two filters were hybridized separately with respective subtracted cDNA library probes and RNA controls overnight at 651C. Filters were washed in 2 Â SSC followed by 2 Â SSC, 1% SDS at 421C and a final stringency wash in 0.6 Â SSC, 1% SDS at 681C. Signals on the filters were detected by phosphorimaging (Molecular Dynamics) and the images were analyzed by Incyte Genomics Genome Discovery software (GDS). Analysis was carried out by global means and signals on filters were normalized so that the total summation of intensity values was the same for both filters. Using the normalized values, each point across the two filters was compared and the absolute difference was obtained.
Genespring analysis: All normalized data were saved as Excel files and then transferred into the GENESPRING software (Version 5.0, Silicon Genetics). We used the standard correlation to produce a Genetree depicting gene expression profiles. The Genetree is based on a correlation of genes with similar expression patterns. Using this statistical model, the correlation for each gene with every other gene in the set was calculated initially producing the highest correlated paired genes, averaging their expression profiles. This process was repeated until all genes had been paired. These genes were then filtered using a 4/o5-fold cutoff mark to analyze a smaller number of genes.
Virtual Northern analysis
Virtual Northern blots were prepared using the same SMART amplified cDNA that was used for subtraction alongside various other samples that served as positive controls. SMART cDNA (1.5 mg) was gel electrophoresed and transferred onto a nylon H þ bond membrane (Amersham Pharmacia). Candidate cDNAs were 32 P labeled by random priming (Amersham Pharmacia). Virtual Northern blots were prehybridized and then hybridized according to Franz et al. 20 The blots were exposed to phosphorimage screens overnight, imaged (Molecular Dynamics, Sunnyvale, CA, USA) and the relative expression was determined. Values were normalized against GAPDH.
Semiquantitative PCR
Semiquantitative PCR of candidate genes was performed using unsubtracted cDNA from affected siblings II-5 and II-6, and unaffected sibling II-3. In addition, cDNA from normal bone marrow CD34 þ cells, normal T cells and the MDS cell lines, P39 and MDS92-L (acquired from Dr Tohayama), were also tested.
Semiquantitative RT PCR was performed in a total volume of 30 ml using 100 ng cDNA, 12 pmol of each primer and 1/10 volume of 10 Â PCR buffer (10 mM Tris-HCL, pH 8.0) (Sigma). Amplification using b-actin primers (annealing temperature of 551C) was carried out to normalize across all the samples. Amplification of each candidate was carried out using a PerkinElmer 9700 (Life Sciences). A 5 ml aliquot was taken from the PCR reaction after 18, 23, 28 and 33 cycles, and the PCR products were analyzed by gel electrophoresis. Size ranges of products were 122-271 bp.
Extraction of proteins from whole-cell lysates and Western analysis
Nuclear and cytoplasmic proteins were extracted from the above-purified cells and cell lines for Western analysis by standard procedures. 21 A total of 1 Â 10 5 cells from each sample were loaded onto 4-12% bis-Tris SDS gels (Invitrogen) and proteins electrophoresed at 200 V. Histones were cut from gel and separately stained in coomassie blue (Pierce) to assess loading, while the rest of the gel was transferred onto nitrocellulose membranes (Invitrogen) for 1 h at 25 V. The membranes were hybridized to primary antibodies (goat antimyeloid nuclear differentiation antigen (MNDA) (Santa Cruz, CA, USA), rabbit anti-cdk6 (Santa Cruz, CA, USA) and washed according to the manufacturer's instructions (Santa Cruz, CA)). The proteins were detected by enhanced chemiluminescence plus (ECL þ ) (Amersham Pharmacia) and exposed onto ECL hyperfilms (Amersham Pharmacia).
Results
MDS family
The proband (II-7) was diagnosed at the age of 40 years with MDS RA and died at the age of 49 years of AML with complex karyotypic abnormalities. One of his sisters died of AML aged 35 (II-1) years. Two sisters (II-5 and II-6) were both diagnosed with MDS RA, with macrocytosis and neutropenia, respectively. Affected II-5 and II-6 had the following blood counts: II-5, Hb 12, MCV 104, WBC 3.2, neutrophils 1.8, lymphocytes 1.1, monocytes 0.2, platelets 155; II-6, Hb 13, MCV 105, WBC 4.5, neutrophils 2.3, lymphocytes 2.1, monocytes 0.3, platelets 4.5. They both have been alive for over 10 years since diagnosis. While sibling II-6 had no detectable cytogenetic abnormalities, sibling II-5 was diagnosed with a balanced translocation t(7;15) (p22; q22.3) in 1990, but demonstrated a normal karyotype in subsequent cytogenetic analyses and at the time of this study. Sibling II-3, aged 42 years, was examined for MDS and considered clinically and morphologically normal ( Figure 1) ; 14, 15 he continues to be normal and healthy. No known consanguinity was documented in this family. Thus, affected CD34 þ and MNC cells from sisters II-5 and II-6, and the unaffected brother II-3, were used in our studies to identify genes that were differentially expressed in adult familial MDS.
Subtractive hybridization of cDNA of mononuclear and CD34 þ cells from affected and unaffected MDS family members
To identify the genes maximally differentially expressed in adult familial MDS, we used an SHH technique 22 to enrich for differences in gene expression between CD34 þ bone marrow cells from affected vs unaffected siblings in our MDS family. This same SSH procedure was also performed on cDNAs of MNC cells from affected vs unaffected siblings. These experiments were repeated three times. In our approach, forward subtraction, wherein cDNA from affected individuals was used as the tester and cDNA from the unaffected sibling as the driver, was used to enrich for genes differentially expressed in subtraction cDNA expression libraries from affected individuals II-5 and II-6 ( Figure 1) . To enrich for genes expressed in unaffected individuals from this family, reverse subtraction was performed where cDNA from the unaffected sibling II-3 were used as the tester and the affected cDNA (from sibling II-5 and II-6 hybridized separately) as the driver, resulting in the expression libraries II-3(1) and II-3(2), respectively. To confirm that SSH was successful, we tested for the depletion of housekeeping genes in our forward and reverse subtracted libraries. The detection of housekeeping genes by PCR at later cycles compared with unsubtracted cDNA controls connoted a concomitant enrichment in tissue-specific transcripts. Previous data demonstrated that a difference of five cycles in the detection of PCR products gave an estimated 10-fold library enrichment. 22 We detected the housekeeping gene GAPDH at 18 cycles in unsubtracted CD34 þ and MNC cDNA as compared to an average of 23-33 cycles in three different sets of SSH experiments for both MNC and CD34 þ cells. Thus, we estimate that our libraries were enriched for rare transcripts by 10-to 30-fold ( Figure 2 ).
Array analysis of cDNA expression libraries from affected and unaffected MDS family members
To determine the profile of differentially expressed genes in familial MDS, cDNA expression libraries from both affected and Pedigree of the index MDS family. Closed symbols represent family members with MDS. Deceased members, including the proband, (arrow) are denoted with a line through the symbols. Asterisks denote affected siblings II-5 and II-6 and unaffected sibling II-3 studied for differential expression of genes.
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A Pradhan et al unaffected family members were radioactively labeled and separately hybridized to nylon membranes of Gene Discovery Arrays, containing 18 404 human genes and expressed sequence tag (ESTs) obtained from the IMAGE consortium (Genbank release 1999, Incyte Genomics). To identify a unique expression profile between affected and unaffected MDS family members, we first performed cluster analysis on all genes expressed in CD34 þ cDNA libraries to identify those genes, in experiments repeated three times, that were 45-fold differentially expressed between affected and unaffected members. Of 18 404 genes and ESTs examined, only 8437 were expressed in the CD34 þ cells of either affected or unaffected siblings (or both) (data not shown). Strikingly, the expression patterns for cDNA expression libraries from the affected siblings were distinctly different compared with unaffected CD34 þ cDNA libraries (Figure 3) . Out of 8437 genes and ESTs expressed in CD34 þ cells, clusters A and B contained 33 genes and ESTs that were the most strikingly underexpressed (45-fold) in affected vs unaffected libraries ( Figure 3b , Table 1 ). The most prominent members of this group encoded transcription factors, such as ZNF140, a krueppel-related domain-associated transcriptional repressor (Genbank accession: U09368), the zinc-finger containing proteins, ZFYVE1 and ZNF173 (Genbank accession: W16516 and W89103), a repressor of Ets-induced transformation (Genbank accession: W86215), FRAP1, a kinase involved in cell cycle regulation (Genbank accession:T75267) and MNDA (Genbank accession: R77519). Out of the 33 (30%) most underexpressed genes, 10 were novel and of as yet unknown function.
Two clusters (C and D) containing 32 genes and ESTs were identified as the most overexpressed (45-fold), compared with control cDNA libraries ( Figure 3c , Table 2 ). Notable members of this group were the b-and a-like globin genes, 20S ribosomal and BRUNOLS, an RNA-binding protein, (Genbank accessions: H12367, AA075425, AA074833 and H38418). Seven genes were involved in immune system regulation, such as Ig Kappa chains V-I, V-III and precursors (Genbank accessions: H25521, H27034, R83213, R86045, H16042, H25625 and H27394) were also found to be part of this cluster of genes overexpressed in the affected CD34 þ libraries. In addition, the Ras homolog AHRB (Genbank accessions AA047505) and the Fos serum response element (SRF; Genbank accessions AA039915) were also among the group of genes overexpressed in familial MDS. Both of these genes are found in pathways known to be altered in sporadic MDS. 23, 24 Eight (25%) of these genes were of unknown function.
Since the CD34 þ genes important in MDS would also be expressed in MNC cells from affected individuals, we next examined the genes differentially expressed in expression libraries from affected vs unaffected both bone marrow MNC and CD34 þ cells. Strikingly, expression libraries for MNC and CD34 þ from affected individuals demonstrated a similar pattern of expression for the two different cell types, as did the respective libraries from unaffected individuals (Figure 4a) . Furthermore, these analyses identified major clusters of differentially expressed genes and ESTs common to both CD34 þ and MNC cells (Figure 4b ). While some of these genes were present in the most differentially expressed CD34 þ gene clusters identified above, new differentially expressed genes, common to CD34 þ and MNC cells, were identified. Out of a total of 5752 genes and ESTs expressed in both CD34 þ and MNC cells from either affected or unaffected siblings, cluster E contained 22 genes and ESTs showing 45-fold downregulation, compared with control cDNA libraries (Figure 4b , Table 3 ). Genes of note in this cluster were the transcription factors, zinc-finger ZNF140 (see above), the zinc-finger MIZIP (Genbank accession: T75462) and the leucine zipper BZWI (Genbank accession: AA16703) and MNDA (see above). Another gene of note was the antigenic marker L-selectin, present on neutrophils and monocytes (Genbank accession: W00575 and CD45 antigen (Genbank accession: R80064). Nine (43%) ESTs represented novel sequences whose functions have yet to be defined. We identified one cluster, F, containing 36 showed 45-fold upregulation, compared with control cDNA libraries (Figure 4b , Table 4 ). While b-globin was the most overexpressed gene in affected siblings, compared to the unaffected control, genes such as the FGF9 (fibroblast growth factor 9) (Genbank accession: H24274), API5, an inhibitor of apoptosis (Genbank accession: H13009) and coilin, an integral component of the coiled body involved in RNA processing (Genbank accession: AA128900) were among those genes most prominently Representative subtraction efficiency in subtracted cDNA expression libraries of CD34 þ cells from affected sibling II-6 and unaffected sibling II-3. Lanes 1-4, 6-9, PCR products of GAPDH at 18, 23, 28 and 33 cycles in unsubtracted and subtracted CD34 þ cDNA, from affected individual II-6. GAPDH is visible at 18 cycles in unsubtracted cDNA from individual II-6, whereas in subtracted cDNA the GAPDH product is only visible at 23 cycles, giving an estimated 10-fold enrichment. [16] [17] [18] [19] Table 1 . (c) Clusters of genes and ESTs 45-fold overexpressed in affected family members, compared with unaffected controls. An arrow points to the most highly upregulated cluster of genes that are enumerated in Table 2 .
A Pradhan et al overexpressed. A large number of ESTs (18 (50%)) in this cluster were novel.
Verification and extension of expression array data
To verify the differential expression of genes in familial MDS obtained from the analysis of microarray data, we performed semiquantitative PCR and virtual Northern analysis of the most downregulated genes in CD34 þ and MNC cells from affected family members, ZNF 140 and MNDA. Our experiments performed at least three times show that these genes were indeed downregulated in adult familial MDS, and confirm our array data (Figures 5 and 6 ). Whereas ZNF140 was not detected by RT-PCR in up to 30 cycles in affected MDS members, connoting a very low and possibly fully silent transcriptional activity (Figure 5b ), MNDA was downregulated approximately 10-fold by semiquantitative PCR (Figures 5a and 6a) . Moreover, virtual Northern analysis (see Materials and methods) of MNDA confirmed a 10-to 20-fold downregulation in MNDA expression (Figure 6a ). To determine whether this expression pattern was common to adult familial MDS, we examined the expression of ZN140 and MNDA in cDNA from two affected members of another MDS family. Affected sibling 1 (II-1 MDS2) was diagnosed in 1996 with MDS RAEB at 78 years of age, while his brother (II-2MDS2) was diagnosed some years later (2001), at the age of 80 years, with hypoplastic anemia and bone marrow failure. Bone marrow cytogenetics from both affected individuals revealed no visible chromosomal abnormalities. We demonstrated in CD34 þ and MNC from these affected brothers that both ZNF140 and MNDA were similarly downregulated in this family (Figures 6a).
To determine whether these gene expression differences extend to sporadic MDS, we next chose to examine the expression of MNDA and ZNF140 in two MDS-derived cell lines, P39 17 and MDS92L. 18 Interestingly, whereas P39 showed normal patterns of expression of ZNF140 and MNDA, MDS92L demonstrated the low expression seen in adult familial MDS (Figures 5 and 6b) .
To further establish the significance of our expression data, we next chose to determine whether differential RNA expression translated into observable differences in protein expression of these genes. We examined MNDA by Western analysis in cell lysates from the two MDS cell lines in addition to five 'low-risk' (four MDS RA and one RARS) and two 'high-risk' MDS RAEB patients. In addition, to confirm the previously described specificity of MNDA expression for the myeloid lineage, we also examined cell lysates from normal T cells (IL-2 stimulated and unstimulated) and MNCs. We confirmed previous data that MNDA protein expression is exclusively expressed in normal bone marrow MNC, whereas it is not expressed in T cells (stimulated and unstimulated, Figure 7) . We demonstrated that, as expected, MNDA protein in the P39 cell line was normal. Strikingly, no MNDA protein was detectable in MDS92L cells (Figure 7) , where the MNDA transcript was shown to be downregulated (see above). Examination of MNDA protein expression in seven sporadic MDS patients (two RAEB, four RA 
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A Pradhan et al and one RARS) yielded surprising results. Whereas the MDS RA and RARS patients showed normal steady-state levels of MNDA, the two 'high-risk' MDS RAEB patients showed an absence of protein expression (Figure 7) . Thus, MNDA expression data for sporadic MDS RA are in contrast to the MDS RA family members who show downregulation of this transcript. Given our expression data for MNDA and ZNF140 in sporadic MDS, we next sought to determine whether there is a spectrum of genes commonly differentially expressed between adult familial and sporadic MDS. We first compared class predictors for sporadic MDS CD34 þ cells with all the genes differentially expressed in adult familial MDS CD34 þ cells. 6 We estimated that only approximately 40% of the genes found to be significantly differentially expressed in sporadic MDS six were present on the Genome Discovery blots. However, the 11 genes (TACSTD2, UQCRC1, TNNC1, KDELR, CLC, H-PLK, RGS19, ATF3, FARP1, GNG7 and TPD52L2) selected by class membership prediction, which were found to be pathognomonic for sporadic MDS, were not present on Genome Discovery array, and thus, assessment of their differential expression in familial MDS was not possible. Nevertheless, among the genes present on our array blots, up to 66% of genes differentially expressed in sporadic MDS were similarly altered in familial MDS (data not shown). However, the most significant spectrum of overlap in differentially expressed genes fell into the 'high-risk' vs healthy individuals (66%) and 'high-risk' vs 'low-risk' (83%) MDS categories. Notably, of the group of 23 genes downregulated in high-risk vs low-risk MDS, six were present on our array blots, and five of these genes (83%; arfaptin 2, L-plastin, MNDA, Craap and a Krueppel-related zinc-finger, not ZNF 140) were significantly underexpressed in affected vs unaffected family members (Figure 8 ). In contrast, an average of only 12.5% of genes differentially expressed in 'low-risk' vs healthy individuals were similarly altered in familial MDS (data not shown). (Table 3 ) Clusters of genes and ESTs 45-fold overexpressed genes in each subtracted affected family member. An arrow denotes those genes that are most highly overexpressed (Table 4) .
A Pradhan et al Table 3 EST's downregulated 45-fold in mononuclear and CD34+ subtracted mRNA in affected MDS siblings II-5 and II-6 
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Discussion
Recent reports have highlighted the importance of gene profiling for the elucidation of genes and pathways transcriptionally altered in sporadic MDS. [4] [5] [6] Although some insights have been gained from the analysis of children with neurofibromatosis type I 7 and familial monosomy 7, 8 little is known about the genes involved in adult familial MDS. We have used a novel approach to identify the genes and pathways important in adult MDS, by enriching for novel transcripts in CD34 þ and MNC cells from affected and unaffected members of a single adult MDS family, followed by hybridization to arrays containing 18 404 genes and ESTs. We have thus for the first time identified a group of genes significantly differentially expressed in affected MDS family members and verified the altered expression of two genes, ZNF140 and MNDA, in this and another adult MDS family. We have generated a unique gene profile of the most highly differentially expressed genes in CD34 þ and MNC cells from two members of an adult MDS family, which is substantially different from that generated for the sporadic disease. Although these gene expression differences may be attributed in part to the different technical approach taken compared with other array studies, we think that the genes differentially expressed in familial MDS may be due to the biological differences between the familial and sporadic disease. Thus, initial enrichment for unique transcripts followed by hybridization to array blots represents a valid and innovative approach for the identification of differentially expressed genes in affected MDS family members, and this strategy may be employed successfully in other settings. Enriched unique transcript libraries for affected 
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A Pradhan et al siblings gave consistent patterns of gene expression and were markedly different from control transcript libraries. Among the genes significantly downregulated in adult familial MDS are a group of transcription factors, containing important DNA-binding moieties, such as the leucine zipper (BZW1), 25 zinc-fingers (ZNFYVE1 and ZNF173) and Kruppel-related domains (ZNF140), [2] [3] [4] [5] [6] 27 key in the regulation of gene transcription. Among these transcription factors, the zinc-fingers have been localized to regions involved in deletions and translocations associated with inherited and malignant syndromes. 26 Interestingly, in contrast to the majority of ZNFs cloned by Tommerup and Vissing, 26 alteration or loss of the ZNF140 has yet to be associated with a disease phenotype. On the other hand, MNDA, one of the genes found to be downregulated in both adult familial MDS and 'high-risk' sporadic MDS, has been shown to form part of a ternary complex with nucleophosmin (NPM) and the transcription factor YY1. 28, 29 Interestingly, NPM located at chromosome 5q35, a region deleted in a large number of MDS patients, has also been shown to participate in chromosomal translocation and subsequent gene fusion events in both myeloid and lymphoid leukemia. [30] [31] [32] Approximately 20 cases of MDS have been reported, where t(3;5) (q25.1;q35) was shown to result in fusion of the 5 0 -end of NPM in frame to the myeloid leukemia factor, MLF1. 30, 33, 34 In addition, MNDA has been shown to alter the expression of DLK1, a member of the family of epidermal growth factor genes, essential for normal hematopoiesis. 6, 35 Thus, alteration of steady-state levels of constituent members of the MNDA, NPM, YY1 protein complex may be critically involved in the differentiation changes of myeloid cells in MDS.
b-globin was the most overexpressed transcript in affected members of this MDS family. Although the increased abundance of b-globin transcript may be a secondary phenomenon, it may indicate that a greater proportion of the CD34 þ and MNC cells were committed to erythropoietic differentiation in the affected vs unaffected subjects. Such an alteration in the distribution of lineages within the CD34 þ and MNC (mainly intermediate precursors) cell populations, with a shift towards erythropoiesis, might well be accounted for by the excess intramedullary apoptosis and attendant anemia and perturbations in levels of endogenous cytokines/hemopoietins that are known to accompany MDS. [36] [37] [38] Among the genes upregulated in adult familial MDS were an Ras homologue ARHB and the Fos-inducible element, SRF, members of transcription pathways known to be altered in sporadic MDS. 23, 24 While increased expression of Fos has been reported in a small number of MDS cases, constitutive expression of Ras homologues through key codon point mutations has been reported as one of the most frequent genetic alterations in MDS. 39 Up to 40% of sporadic MDS patients have been shown to have Ras mutations, the majority of whom were 'high-risk' MDS. 38 Another gene upregulated in both sporadic and familial MDS, coilin, a part of nucleolar Cajal bodies, is thought to be involved in RNA processing and cellular trafficking. 40 A model has been proposed in which Cajal bodies are the sites for preassembly of transcriptosomes, unitary particles involved in transcription and processing of RNA. 41 The finding that a key downregulated gene in affected members of our MDS family, MNDA, showed a similar pattern of expression in 'high-risk' sporadic MDS cases, prompted an extensive examination of all differentially expressed genes in our family. We found that the most significant overlap of differentially expressed genes occurred between familial MDS and 'high-risk' MDS categories, further strengthening our initial findings. Although the basis for similar specific gene expression patterns between these familial MDS and 'high-risk' sporadic disease types is unclear, the order in which specific pathways necessary for the MDS phenotype are altered may be different in familial MDS. Predisposition genes, as yet unknown, may prime dysregulation of the MNDA complex at an earlier stage of disease progression, compared with sporadic counterparts. Nevertheless, these data suggest that although familial MDS may be generated by a unique spectrum of genes predisposing to this disease, some of the same molecular pathways may also be involved in both the sporadic and familial disease. Finally, this study provides insights into the biology of familial MDS, showing alterations in a number of key pathways involved in cell signaling, growth and differentiation. Several of these proteins and their binding partners represent important molecules for further research into the familial form of this disease. Furthermore, the key pathways that are altered in both sporadic and familial MDS emphasize that these pathway constituents are likely to be important targets in new strategies for the treatment of MDS as a whole. Expression of genes in adult familial MDS known to be differentially expressed in 'high-risk' MDS. Bar graph of the gene expression in six genes found on our arrays out of a total of 23 genes; (Arfaptin 2, (CRAAP) cisplatin resistance-associated alpha protein, a Kruppel related zinc-finger, L-plastin, MNDA and TDGF 1 (teratocarcinoma-derived growth factor 1) in affected and unaffected MDS family members. These genes are known to be downregulated in 'high-risk' sporadic MDS vs low-risk sporadic MDS. Craap, Arfaptin 2, L-plastin, a Kruppel-related zin-finger (not ZNF140) and MNDA were downregulated in both affected family members, compared with the unaffected control. The expression values were derived after normalization using standard correlation.
A Pradhan et al
